Suppr超能文献

使用单管多重PCR检测引起人类呼吸道感染的微生物

Detection of Microorganisms Causing Human Respiratory Infection Using One-Tube Multiplex PCR.

作者信息

Lima Isabela L, Neves Adriana F, Oliveira-Júnior Robson J, Honório Lorrayne C M G, Arruda Vitória O, São Julião Juliana A, Goulart Filho Luiz Ricardo, Alonso-Goulart Vivian

机构信息

Instituto de Biotecnologia, Universidade Federal de Uberlândia, Uberlândia 38405-302, Minas Gerais, Brazil.

Instituto de Biotecnologia, Universidade Federal de Catalão, Catalão 75704-020, Goiás, Brazil.

出版信息

Infect Dis Rep. 2025 Aug 4;17(4):93. doi: 10.3390/idr17040093.

Abstract

Due to the significant overlap in symptoms between COVID-19 and other respiratory infections, a multiplex PCR-based platform was developed to simultaneously detect 22 respiratory pathogens. Target sequences were retrieved from the GenBank database and aligned using Clustal Omega 2.1 to identify conserved regions prioritized for primer design. Primers were designed using Primer Express 3.0.1 and evaluated in Primer Explorer to ensure specificity and minimize secondary structures. A multiplex strategy organized primers into three groups, each labeled with distinct fluorophores (FAM, VIC, or NED), allowing for detection by conventional PCR or capillary electrophoresis (CE). After reverse transcription for RNA targets, amplification was performed in a single-tube reaction. A total of 340 clinical samples-nasopharyngeal and saliva swabs-were collected from patients, during the COVID-19 pandemic period. The automated analysis of electropherograms enabled precise pathogen identification. Of the samples analyzed, 57.1% tested negative for all pathogens. SARS-CoV-2 was the most frequently detected pathogen (29%), followed by enterovirus (6.5%). Positive results were detected in both nasopharyngeal and saliva swabs, with SARS-CoV-2 predominating in saliva samples. This single-tube multiplex PCR-CE assay represents a cost-effective and robust approach for comprehensive respiratory pathogen detection. It enables rapid and simultaneous diagnosis, facilitating targeted treatment strategies and improved patient outcomes.

摘要

由于新冠病毒(COVID-19)与其他呼吸道感染的症状存在显著重叠,因此开发了一种基于多重聚合酶链反应(PCR)的平台,用于同时检测22种呼吸道病原体。从GenBank数据库中检索目标序列,并使用Clustal Omega 2.1进行比对,以识别优先用于引物设计的保守区域。使用Primer Express 3.0.1设计引物,并在Primer Explorer中进行评估,以确保特异性并最小化二级结构。一种多重策略将引物分为三组,每组用不同的荧光团(FAM、VIC或NED)标记,从而可以通过常规PCR或毛细管电泳(CE)进行检测。对RNA靶标进行逆转录后,在单管反应中进行扩增。在COVID-19大流行期间,从患者那里总共收集了340份临床样本——鼻咽拭子和唾液拭子。电泳图的自动分析能够精确识别病原体。在分析的样本中,57.1%的样本对所有病原体检测均为阴性。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是最常检测到的病原体(29%),其次是肠道病毒(6.5%)。在鼻咽拭子和唾液拭子中均检测到阳性结果,SARS-CoV-2在唾液样本中占主导地位。这种单管多重PCR-CE检测方法是一种经济高效且强大的全面呼吸道病原体检测方法。它能够实现快速、同时诊断,有助于制定针对性的治疗策略并改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252e/12385970/d3916f2f64e7/idr-17-00093-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验